SCHEMBL3487214

SCHEMBL3487214

Cc1cccc(Oc2ccc(N)c(CNC(=O)O)c2)c1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.54
MEN1 O00255 1/20 0.46
MAPT P10636 1/20 0.46
KMT2A Q03164 1/20 0.46
GFER P55789 2/20 0.45
MAPK1 P28482 1/20 0.45
GAA P10253 1/20 0.44
LMNA P02545 1/20 0.44
LTA4H P09960 1/20 0.44
FFAR1 O14842 1/20 0.44
GLA P06280 1/20 0.43
SMN1; SMN2 Q16637 1/20 0.43
CDK8 P49336 1/20 0.43
HSD17B1 P14061 1/20 0.42
HSD17B2 P37059 1/20 0.42
TDP1 Q9NUW8 2/20 0.42
POLB P06746 1/20 0.42
L3MBTL1 Q9Y468 2/20 0.42
HTT P42858 1/20 0.42
EZH2 Q15910 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3487614 0.88 SMN1; SMN2 (0.52) ALDH1A1MEN1KMT2ASMN1; SMN2POLB
SCHEMBL3488176 0.88 TEAD4 (0.46) ALDH1A1MAPTGFERSMN1; SMN2TDP1
SCHEMBL3487570 0.86 MMP13 (0.42) ALDH1A1MAPK1LTA4HFFAR1SMN1; SMN2
SCHEMBL3487598 0.86 HTR2A (0.44) LMNAFFAR1CDK8KLKB1
SCHEMBL3489383 0.85 ALDH1A1 (0.42) ALDH1A1MEN1MAPTKMT2ASMN1; SMN2
SCHEMBL3488403 0.84 SMN1; SMN2 (0.42) ALDH1A1MEN1MAPTKMT2AGFER
SCHEMBL3488380 0.84 RAF1 (0.44) ALDH1A1MAPTSMN1; SMN2POLBHTT
SCHEMBL3488929 0.84 ALDH1A1 (0.41) ALDH1A1MAPTSMN1; SMN2HTT
SCHEMBL3488473 0.83 MAPK14 (0.51) LTA4H
SCHEMBL3487535 0.83 MAPK14 (0.51) MAPTCDK8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2138484-B1 FUSED BICYCLIC HETEROARYL DERIVATIVES DAIICHI SANKYO CO LTD (JP) 2015-08-26 EP disclosed
US-20100048564-A1 FUSED BICYCLIC HETEROARYL DERIVATIVE DAIICHI SANKYO COMPANY, LIMITED (JP) 2010-02-25 US disclosed
EP-2138484-A1 FUSED BICYCLIC HETEROARYL DERIVATIVES Daiichi Sankyo Company, Limited (JP) 2009-12-30 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100048564-A1 FUSED BICYCLIC HETEROARYL DERIVATIVE PPARG, GPR119, PPARA ALDH1A1 698/4885MEN1 4545/4885MAPT 4610/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.